| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.01 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |